Clinical Trial Update: T-GENVIH-003 LTFU (Long Term Follow Up) Study

View source ↗

Summary

Integra LifeSciences reports completion of the long-term follow-up (LTFU) for the T-GENVIH-003 study in patients with ventral/abdominal hernia; results have bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Hernia
• Hernia
• Ventral Hernia

Drugs mentioned

• T-GENVIH-003

Snippet

Sponsor: Integra LifeSciences Corporation | Conditions: Hernia, Hernia, Ventral | Status: COMPLETED | Results posted: 2025-05-20